Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wade L Thorstad

Showing results (51-60 of 96) with videos related to

Pageof 10
Sort By:
Laryngoscope Investigative Otolaryngology|April 28, 2020
Childhood tonsillectomy alters the primary distribution of HPV-related oropharyngeal squamous cell carcinomaBrannon Altenhofen, Todd A DeWees, Ji W Ahn, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 20, 2023
Hearing Outcomes in a Deintensification Trial of Adjuvant Therapy for HPV-Related Oropharyngeal Squamous Cell CarcinomaDavid S Lee, Rajwant S Mahal, Theresa Tharakan, et al.
Journal of the National Cancer Institute|October 15, 2020
A MicroRNA Expression Signature as Prognostic Marker for Oropharyngeal Squamous Cell CarcinomaXinyi Liu, Ping Liu, Rebecca D Chernock, et al.
Cancer Medicine|July 16, 2018
Induction chemotherapy in the treatment of nasopharyngeal carcinoma: Clinical outcomes and patterns of carePrashant Gabani, Justin Barnes, Alexander J Lin, et al.
Physics in Medicine and Biology|June 13, 2017
Predictive modeling of outcomes following definitive chemoradiotherapy for oropharyngeal cancer based on FDG-PET image characteristicsMichael R Folkert, Jeremy Setton, Aditya P Apte, et al.
Radiation Oncology (London, England)|January 10, 2015
Pre-radiotherapy feeding tube identifies a poor prognostic subset of postoperative p16 positive oropharyngeal carcinoma patientsVivek Verma, Jingxia Liu, Laura Eschen, et al.
Head & Neck|July 28, 2018
Pretreatment metabolic tumor volume as a prognostic factor in HPV-associated oropharyngeal cancer in the context of AJCC 8th edition stagingJohn M Floberg, Todd A DeWees, Re-I Chin, et al.
JCO Precision Oncology|May 22, 2025
Palbociclib, a Selective CDK4/6 Inhibitor, Administered Before and After Chemoradiotherapy for Human Papillomavirus-Negative, Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm, Phase II TrialPeter J Oppelt, Jessica C Ley, Sidharth V Puram, et al.
The Laryngoscope|September 17, 2016
Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinomaJoseph Zenga, Ryan S Jackson, Evan M Graboyes, et al.
JAMA Otolaryngology-- Head & Neck Surgery|April 23, 2015
Treatment Outcomes for T4 Oropharyngeal Squamous Cell CarcinomaJoseph Zenga, Michael Wilson, Douglas R Adkins, et al.
Pageof 10

Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Laryngoscope Investigative Otolaryngology|April 28, 2020
Childhood tonsillectomy alters the primary distribution of HPV-related oropharyngeal squamous cell carcinomaBrannon Altenhofen, Todd A DeWees, Ji W Ahn, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 20, 2023
Hearing Outcomes in a Deintensification Trial of Adjuvant Therapy for HPV-Related Oropharyngeal Squamous Cell CarcinomaDavid S Lee, Rajwant S Mahal, Theresa Tharakan, et al.
Journal of the National Cancer Institute|October 15, 2020
A MicroRNA Expression Signature as Prognostic Marker for Oropharyngeal Squamous Cell CarcinomaXinyi Liu, Ping Liu, Rebecca D Chernock, et al.
Cancer Medicine|July 16, 2018
Induction chemotherapy in the treatment of nasopharyngeal carcinoma: Clinical outcomes and patterns of carePrashant Gabani, Justin Barnes, Alexander J Lin, et al.
Physics in Medicine and Biology|June 13, 2017
Predictive modeling of outcomes following definitive chemoradiotherapy for oropharyngeal cancer based on FDG-PET image characteristicsMichael R Folkert, Jeremy Setton, Aditya P Apte, et al.
Radiation Oncology (London, England)|January 10, 2015
Pre-radiotherapy feeding tube identifies a poor prognostic subset of postoperative p16 positive oropharyngeal carcinoma patientsVivek Verma, Jingxia Liu, Laura Eschen, et al.
Head & Neck|July 28, 2018
Pretreatment metabolic tumor volume as a prognostic factor in HPV-associated oropharyngeal cancer in the context of AJCC 8th edition stagingJohn M Floberg, Todd A DeWees, Re-I Chin, et al.
JCO Precision Oncology|May 22, 2025
Palbociclib, a Selective CDK4/6 Inhibitor, Administered Before and After Chemoradiotherapy for Human Papillomavirus-Negative, Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm, Phase II TrialPeter J Oppelt, Jessica C Ley, Sidharth V Puram, et al.
The Laryngoscope|September 17, 2016
Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinomaJoseph Zenga, Ryan S Jackson, Evan M Graboyes, et al.
JAMA Otolaryngology-- Head & Neck Surgery|April 23, 2015
Treatment Outcomes for T4 Oropharyngeal Squamous Cell CarcinomaJoseph Zenga, Michael Wilson, Douglas R Adkins, et al.
Pageof 10